Medical Data Vision Co., Ltd. (TYO:3902)
Japan
· Delayed Price · Currency is JPY 1,681.00
+1.00 (0.06%)
Mar 10, 2026, 10:50 AM JST
Medical Data Vision Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,713 | 1,347 | 3,218 | 2,264 | 3,221 | Upgrade
|
| Cash & Short-Term Investments | 1,713 | 1,347 | 3,218 | 2,264 | 3,221 | Upgrade
|
| Cash Growth | 27.17% | -58.14% | 42.14% | -29.71% | 0.84% | Upgrade
|
| Receivables | 1,038 | 977 | 1,103 | 965 | 1,056 | Upgrade
|
| Inventory | 20 | 9 | 6 | 13 | 11 | Upgrade
|
| Prepaid Expenses | 299 | 345 | - | - | - | Upgrade
|
| Other Current Assets | 286 | 433 | 335 | 282 | 237 | Upgrade
|
| Total Current Assets | 3,356 | 3,111 | 4,662 | 3,524 | 4,525 | Upgrade
|
| Property, Plant & Equipment | 243 | 238 | 158 | 137 | 140 | Upgrade
|
| Long-Term Investments | 460 | 865 | 965 | 651 | 333 | Upgrade
|
| Goodwill | 38 | 64 | 89 | 257 | 222 | Upgrade
|
| Other Intangible Assets | - | - | 1 | 2 | 5 | Upgrade
|
| Long-Term Deferred Tax Assets | 606 | 383 | 344 | 324 | 308 | Upgrade
|
| Other Long-Term Assets | 2 | 2 | 2 | 2 | 1 | Upgrade
|
| Total Assets | 4,778 | 4,749 | 6,221 | 4,897 | 5,534 | Upgrade
|
| Accounts Payable | 281 | 218 | 140 | 93 | 97 | Upgrade
|
| Accrued Expenses | 15 | - | 5 | 4 | 28 | Upgrade
|
| Current Income Taxes Payable | 318 | 343 | 478 | 95 | 400 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 353 | Upgrade
|
| Other Current Liabilities | 896 | 877 | 1,182 | 1,014 | 365 | Upgrade
|
| Total Current Liabilities | 1,510 | 1,438 | 1,805 | 1,206 | 1,243 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5 | 5 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 154 | 154 | 100 | 85 | 86 | Upgrade
|
| Total Liabilities | 1,669 | 1,597 | 1,905 | 1,291 | 1,329 | Upgrade
|
| Common Stock | 992 | 992 | 992 | 992 | 992 | Upgrade
|
| Additional Paid-In Capital | 1,786 | 1,838 | 1,838 | 1,838 | 1,763 | Upgrade
|
| Retained Earnings | 2,790 | 2,756 | 3,795 | 3,045 | 2,879 | Upgrade
|
| Treasury Stock | -2,494 | -2,494 | -2,341 | -2,341 | -1,479 | Upgrade
|
| Comprehensive Income & Other | 7 | 7 | -33 | -18 | 1 | Upgrade
|
| Total Common Equity | 3,081 | 3,099 | 4,251 | 3,516 | 4,156 | Upgrade
|
| Minority Interest | 28 | 53 | 65 | 90 | 49 | Upgrade
|
| Shareholders' Equity | 3,109 | 3,152 | 4,316 | 3,606 | 4,205 | Upgrade
|
| Total Liabilities & Equity | 4,778 | 4,749 | 6,221 | 4,897 | 5,534 | Upgrade
|
| Net Cash (Debt) | 1,713 | 1,347 | 3,218 | 2,264 | 3,221 | Upgrade
|
| Net Cash Growth | 27.17% | -58.14% | 42.14% | -29.71% | 0.84% | Upgrade
|
| Net Cash Per Share | 45.25 | 35.30 | 84.25 | 59.21 | 82.19 | Upgrade
|
| Filing Date Shares Outstanding | 37.86 | 37.86 | 38.2 | 38.2 | 38.2 | Upgrade
|
| Total Common Shares Outstanding | 37.86 | 37.86 | 38.2 | 38.2 | 38.96 | Upgrade
|
| Working Capital | 1,846 | 1,673 | 2,857 | 2,318 | 3,282 | Upgrade
|
| Book Value Per Share | 81.39 | 81.86 | 111.29 | 92.05 | 106.67 | Upgrade
|
| Tangible Book Value | 3,043 | 3,035 | 4,161 | 3,257 | 3,929 | Upgrade
|
| Tangible Book Value Per Share | 80.38 | 80.17 | 108.94 | 85.27 | 100.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.